TScan Therapeutics Announces Pricing Of Public Offering – Quick Facts

(RTTNews) – TScan Therapeutics, Inc. (TCRX) announced the pricing of an underwritten public offering of 2,472,581 shares of voting common stock at a public offering price of the market price of $7.1300 per share, and pre-funded warrants to purchase up to an aggregate of 18,577,41

admin